166 related articles for article (PubMed ID: 10729776)
41. Generation of nitric oxide by the inducible nitric oxide synthase protects gamma delta T cells from Mycobacterium tuberculosis-induced apoptosis.
Sciorati C; Rovere P; Ferrarini M; Paolucci C; Heltai S; Vaiani R; Clementi E; Manfredi AA
J Immunol; 1999 Aug; 163(3):1570-6. PubMed ID: 10415061
[TBL] [Abstract][Full Text] [Related]
42. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
43. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
44. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
45. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
46. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
Aggarwal S; Gupta S
J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
[TBL] [Abstract][Full Text] [Related]
47. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.
Mariani SM; Krammer PH
Eur J Immunol; 1998 May; 28(5):1492-8. PubMed ID: 9603453
[TBL] [Abstract][Full Text] [Related]
48. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
[TBL] [Abstract][Full Text] [Related]
49. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
[TBL] [Abstract][Full Text] [Related]
50. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
51. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
52. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
Park CS; Yashiro Y; Tai XG; Toyo-oka K; Hamaoka T; Yagita H; Okumura K; Neben S; Fujiwara H
J Immunol; 1998 Jun; 160(12):5790-6. PubMed ID: 9637489
[TBL] [Abstract][Full Text] [Related]
53. Enhanced proliferation and defective activation-induced cell death of CD4+ T cells in childhood asthma.
Jiang T; Sheng J; Qin Y; Xiong H; Gong Y; Tang H; Zhou J; Deng Z; Zhang H; Cui Y; Qian J; Shen Y; Jin Y
Asian Pac J Allergy Immunol; 2014 Mar; 32(1):75-83. PubMed ID: 24641294
[TBL] [Abstract][Full Text] [Related]
54. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
55. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
Kovacs B; Liossis SN; Dennis GJ; Tsokos GC
Autoimmunity; 1997; 25(4):213-21. PubMed ID: 9344329
[TBL] [Abstract][Full Text] [Related]
56. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
[TBL] [Abstract][Full Text] [Related]
57. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
[TBL] [Abstract][Full Text] [Related]
58. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
59. Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.
Zhang Y; Xu G; Zhang L; Roberts AI; Shi Y
J Immunol; 2008 Jul; 181(1):190-6. PubMed ID: 18566384
[TBL] [Abstract][Full Text] [Related]
60. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
